28.02.2013 Views

The Principles of Clinical Cytogenetics - Extra Materials - Springer

The Principles of Clinical Cytogenetics - Extra Materials - Springer

The Principles of Clinical Cytogenetics - Extra Materials - Springer

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Human Chromosome Nomenclature 53<br />

Table 4<br />

Selected List <strong>of</strong> Symbols and Abbreviations Used for In Situ Hybridization (ish) Nomenclature<br />

Abbreviation<br />

or Symbol Description<br />

– Absent on a specific chromosome<br />

+ Present on a specific chromosome<br />

++ Duplication on a specific chromosome<br />

x Precedes the number <strong>of</strong> signals seen<br />

. Period, separates cytogenetic results from ish results<br />

con Connected or adjacent signals<br />

ish Refers to in situ hybridization; when used by itself, ish refers to hybridization to chromosomes<br />

nuc ish Nuclear or interphase in situ hybridization<br />

pcp Partial chromosome paint<br />

sep Separated signals (which are usually adjacent)<br />

wcp Whole chromosome paint<br />

Note: For a complete listing <strong>of</strong> symbols and abbreviations, refer to ISCN 2005 (12).<br />

<strong>The</strong> second cell line contains the sex chromosomes and all <strong>of</strong> the abnormalities present in the first:<br />

47,XY,del(5)(q13q33),+8,t(9;22)(q34;q11.2)[4]/48,idem,+9,i(17)(q10)[12]/46,XY[4]<br />

�<br />

plus an additional copy <strong>of</strong> chromosome 9:<br />

47,XY,del(5)(q13q33),+8,t(9;22)(q34;q11.2)[4]/48,idem,+9,i(17)(q10)[12]/46,XY[4]<br />

�<br />

and an isochromosome for the long arm <strong>of</strong> chromosome 17:<br />

47,XY,del(5)(q13q33),+8,t(9;22)(q34;q11.2)[4]/48,idem,+9,i(17)(q10)[12]/46,XY[4].<br />

�<br />

Because this is the largest clone present (with 12 cells), it represents the mainline.<br />

Finally, as mentioned above, the third cell line represents cells with a normal male karyotype:<br />

47,XY,del(5)(q13q33),+8,t(9;22)(q34;q11.2)[4]/48,idem,+9,i(17)(q10)[12]/46,XY[4]<br />

�<br />

In the next example there are three cell lines; the stemline and two diverging sidelines.<br />

46,XY,inv(16)(p13q22)[7]/47,sl,+22[8]/46,sdl1,–7[5]<br />

<strong>The</strong> stemline consists <strong>of</strong> seven cells with an XX sex chromosome complement and an inverted chromosome16.<br />

<strong>The</strong> first sideline consists <strong>of</strong> eight cells that also have an XX sex chromosome complement<br />

and the inverted 16 (indicated by the abbreviation sl), but also have an additional chromosome 22. <strong>The</strong><br />

second sideline consists <strong>of</strong> five cells with an XX sex chromosome complement, the inverted 16, the<br />

additional chromosome 22 (indicated by the abbreviation sdl1), and monosomy 7.<br />

Thus, we see that by examining the components <strong>of</strong> a reported karyotype using the above-outlined<br />

rules, together with the abbreviations listed in Table 3 or in the nomenclature document itself (12),<br />

what initially might appear as an indecipherable compilation <strong>of</strong> numbers and symbols becomes a<br />

concise, universal method <strong>of</strong> describing the results <strong>of</strong> a patient’s chromosome analysis.<br />

FLUORESCENCE AND OTHER IN SITU HYBRIDIZATION<br />

Recent advances in human cytogenetics include the development and application <strong>of</strong> in situ hybridization<br />

(ish) protocols to incorporate and bind labeled, cloned DNA or RNA sequences to cytological<br />

preparations. <strong>The</strong>se techniques facilitate the localization <strong>of</strong> specific genes and DNA segments onto<br />

specific chromosomes, ordering the position and orientation <strong>of</strong> adjacent genes along a specific chromosome,<br />

identification <strong>of</strong> microduplications or microdeletions <strong>of</strong> loci that lie beyond the resolution <strong>of</strong><br />

conventional cytogenetics but manifest themselves as abnormal clinical phenotypes, and the detection<br />

<strong>of</strong> aneuploidies involving whole chromosomes or chromosomal regions (see Chapter 17). For these<br />

reasons, nomenclature to designate various ish applications was introduced in ISCN 1995. <strong>The</strong> symbols<br />

and abbreviations used in ish nomenclature are listed in Table 4.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!